However, given the few papers reporting clinical-metabolic variables, a more comprehensive analysis of the possible involvement of cord blood leptin in the pathophysiology of GDM and maternal-fetal outcomes in these patients has not been possible. The gene discussed is LEP; the disease is gestational diabetes.